MATTHEW L. CRAWLEY, PHD, is the Director of the Community Physician Electronic Medical Records Program at Main Line Health. Previously, he has worked as a medicinal chemist at Pfizer and Wyeth Research. Dr. Crawley is an author of more than twenty publications, and his discoveries have resulted in several patents. BARRY M. TROST, PHD, is Tamaki Professor of Humanities and Sciences in the Department of Chemistry at Stanford University. Dr. Trost has been elected a Fellow of the American Academy of Sciences and member of the National Academy of Sciences. He has served as chairman of the NIH Medicinal Chemistry Study Section, held over 120 university lectureships, and presented over 260 plenary lectures at national and international meetings.

“The book will be particularly appreciated by young scientists, especially those aspiring to a future in the pharmaceutical industry, because it shows what kind of problems they will be asked to solve once they start their industrial career.”  (ChemMedChem, 1 March 2013)“All chapters are well-written and comprehensive with lots of examples from OPR and D.  The book is highly recommended to all process chemists.”  (Organic Process Research & Development Journal, 1 November 2012)

• Preface viiContributors ixAbout the Authors xi1 Transition Metal Catalysis in the Pharmaceutical Industry 1Carl A. Busacca, Daniel R. Fandrick, Jinhua J. Song, and Chris H. Senanayake (Boehringer Ingelheim Pharmaceuticals)2 Selected Applications of Transition Metal-Catalyzed Carbon–Carbon Cross-Coupling Reactions in the Pharmaceutical Industry 25Hong C. Shen (Roche)3 Selected Applications of Pd- and Cu-Catalyzed Carbon–Heteroatom Cross-Coupling Reactions in the Pharmaceutical Industry 97Jingjun Yin (Merck)4 Asymmetric Cross-Coupling Reactions 165Vince Yeh (Novartis) and William A. Szabo (Consultant in Drug Development)5 Metathesis Reactions 215Oliver R. Thiel (Amgen)6 Transition Metal-Catalyzed Synthesis of Five- and Six-Membered Heterocycles 257Cheol K. Chung (Merck) and Matthew L. Crawley (Main Line Health)7 Oxidative Catalysis 277Lamont Terrell (GlaxoSmithKline)8 Industrial Asymmetric Hydrogenation 315Hans-Ulrich Blaser (Solvias)Index 243

MATTHEW L. CRAWLEY, PHD, is the Director of the Community Physician Electronic Medical Records Program at Main Line Health. Previously, he has worked as a medicinal chemist at Pfizer and Wyeth Research. Dr. Crawley is an author of more than twenty publications, and his discoveries have resulted in several patents. BARRY M. TROST, PHD, is Tamaki Professor of Humanities and Sciences in the Department of Chemistry at Stanford University. Dr. Trost has been elected a Fellow of the American Academy of Sciences and member of the National Academy of Sciences. He has served as chairman of the NIH Medicinal Chemistry Study Section, held over 120 university lectureships, and presented over 260 plenary lectures at national and international meetings.

“The book will be particularly appreciated by young scientists, especially those aspiring to a future in the pharmaceutical industry, because it shows what kind of problems they will be asked to solve once they start their industrial career.”  (ChemMedChem, 1 March 2013)“All chapters are well-written and comprehensive with lots of examples from OPR and D.  The book is highly recommended to all process chemists.”  (Organic Process Research & Development Journal, 1 November 2012)

• Preface viiContributors ixAbout the Authors xi1 Transition Metal Catalysis in the Pharmaceutical Industry 1Carl A. Busacca, Daniel R. Fandrick, Jinhua J. Song, and Chris H. Senanayake (Boehringer Ingelheim Pharmaceuticals)2 Selected Applications of Transition Metal-Catalyzed Carbon–Carbon Cross-Coupling Reactions in the Pharmaceutical Industry 25Hong C. Shen (Roche)3 Selected Applications of Pd- and Cu-Catalyzed Carbon–Heteroatom Cross-Coupling Reactions in the Pharmaceutical Industry 97Jingjun Yin (Merck)4 Asymmetric Cross-Coupling Reactions 165Vince Yeh (Novartis) and William A. Szabo (Consultant in Drug Development)5 Metathesis Reactions 215Oliver R. Thiel (Amgen)6 Transition Metal-Catalyzed Synthesis of Five- and Six-Membered Heterocycles 257Cheol K. Chung (Merck) and Matthew L. Crawley (Main Line Health)7 Oxidative Catalysis 277Lamont Terrell (GlaxoSmithKline)8 Industrial Asymmetric Hydrogenation 315Hans-Ulrich Blaser (Solvias)Index 243